TP53 Mutations (CLL)

Complete sequencing of the TP53 gene (tumor suppressor p53) using Next Generation sequencing (AmpliSeq TP53 Panel), technical detection limit 3% (corresponds to 6% mutant nucleated cells). | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).